Results of the international Perinatal Outcomes in the Pandemic (iPOP) Study, published in Nature Human Behaviour this month, received media coverage in the New York Times and CityNews. The iPOP Study was co-led by THRiVE co-Directors Meghan Azad and Natalie Rodriguez, along with THRiVE Postdoc Merilee Brockway, and colleagues from Australia and the UK.

THRiVE Lab members and colleagues published results of the International Perinatal Outcomes in the Pandemic (iPOP) Study in Nature Human Behaviour this week. With over 100 co-authors, the iPOP Study investigated associations between early COVID-19 pandemic response measures ('lockdowns') and preterm birth rates, using harmonized data from 52 million births in 26 countries. The iPOP Study was co-led by THRiVE co-directors, Dr. Meghan Azad and Natalie Rodriguez, along with THRiVE Postdoc, Merilee Brockway, and colleagues from Australia and the UK. Read more on the CHRIM News Archive. Read the full article [PDF] and check out Dr. Azad's [Tweetorial] on Twitter.